SUNNYVALE, Calif., Oct. 29 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today feedback from Creekside Cancer Care on their use of the CyberKnife VSI System. Creekside Cancer Care was the first facility in the world to install and begin treating patients with the CyberKnife VSI System. Patient treatments began in June 2010 and clinicians at Creekside Cancer Care quickly reported that average treatment times are less than 30 minutes.
The CyberKnife VSI System, launched in November 2009, is the latest addition to the CyberKnife product family. The CyberKnife VSI System leverages the versatility, simplicity, and intelligence of the CyberKnife System to broaden the range of treatment options physicians can offer their patients - from radiosurgery to include conventionally fractionated Robotic IMRT™. The CyberKnife VSI System features a world-class 1,000 MU/minute X-band linear accelerator, advanced visualization capabilities, automated segmentation capabilities and logical workflow enhancements designed to streamline the physician and patient experience.
To date Creekside Cancer Care has treated more than 45 patients using the new CyberKnife VSI System across a variety of indications including prostate, head and neck, lung, spine and liver. In addition to traditional intracranial radiosurgery and expanded whole body radiosurgery, clinicians at Creekside are regularly using the latest capability of the CyberKnife VSI System, Robotic IMRT, to address prostate cancer. The enhanced spectrum of treatment options allows for more customized treatment plans based on patient-specific situations and conditions, such as patients requiring re-irradiation of previously treated